CIBC Private Wealth Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$4.94M Buy
29,714
+21,735
+272% +$3.64M 0.01% 436
2025
Q3
$1.56M Buy
7,979
+24
+0.3% +$3.95K ﹤0.01% 617
2025
Q2
$719K Sell
7,955
-1,159
-13% -$91.6K ﹤0.01% 741
2025
Q1
$490K Buy
9,114
+5,464
+150% +$505K ﹤0.01% 818
2024
Q4
$477K Buy
3,650
+1,125
+45% +$106K ﹤0.01% 878
2024
Q3
$132K Buy
2,525
+406
+19% +$19.1K ﹤0.01% 1370
2024
Q2
$125K Buy
+2,119
New +$147K ﹤0.01% 1311

Other funds holding ALAB

CIBC Private Wealth Group's ALAB Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Astera Labs (ALAB) stake by 272% in Q4 2025, buying an estimated $3.64M and bringing the position to 29,714 shares worth $4.94M. The position accounts for 0.01% of the portfolio, ranked #436.

CIBC Private Wealth Group first reported a position in ALAB in Q2 2024 and has held it in 7 quarters since. 701 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

  • CIBC Private Wealth Group held 29,714 shares of Astera Labs worth $4.94M as of Q4 2025.
  • CIBC Private Wealth Group bought 21,735 Astera Labs shares in Q4 2025, an estimated $3.64M.
  • Astera Labs made up 0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #436 holding.
  • CIBC Private Wealth Group first reported a position in Astera Labs in Q2 2024 and has held it in 7 quarters since.
  • 701 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.